293 related articles for article (PubMed ID: 26740120)
21. [Could oral antidiabetic agents be useful in the management of different types of diabetes and syndromes of insulin resistance in children and adolescents?].
Otto-Buczkowska E; Nowowiejska B; Jarosz-Chobot P; Stańczyk J
Przegl Lek; 2009; 66(7):388-93. PubMed ID: 20043582
[TBL] [Abstract][Full Text] [Related]
22. The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis.
Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Nutter B; Jain A; Atreja A; Zimmerman RS
Diabet Med; 2012 Aug; 29(8):1029-35. PubMed ID: 22248043
[TBL] [Abstract][Full Text] [Related]
23. Repositioning metformin for cancer prevention and treatment.
Quinn BJ; Kitagawa H; Memmott RM; Gills JJ; Dennis PA
Trends Endocrinol Metab; 2013 Sep; 24(9):469-80. PubMed ID: 23773243
[TBL] [Abstract][Full Text] [Related]
24. Oral hypoglycemic agents in type II diabetes mellitus.
Lubbos H; Miller JL; Rose LI
Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
[TBL] [Abstract][Full Text] [Related]
25. Effects of oral hypoglycemic agents on platelet function.
Papazafiropoulou A; Papanas N; Pappas S; Maltezos E; Mikhailidis DP
J Diabetes Complications; 2015 Aug; 29(6):846-51. PubMed ID: 26026848
[TBL] [Abstract][Full Text] [Related]
26. Exploring the role of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus.
Graham JP; Stam D
Pharm Pract Manag Q; 1997 Oct; 17(3):1-9. PubMed ID: 10173306
[TBL] [Abstract][Full Text] [Related]
27. Rapamycin/metformin co-treatment normalizes insulin sensitivity and reduces complications of metabolic syndrome in type 2 diabetic mice.
Reifsnyder PC; Flurkey K; Doty R; Calcutt NA; Koza RA; Harrison DE
Aging Cell; 2022 Sep; 21(9):e13666. PubMed ID: 35986566
[TBL] [Abstract][Full Text] [Related]
28. Metformin may improve the prognosis of patients with pancreatic cancer.
Zhang JW; Sun Q
Asian Pac J Cancer Prev; 2015; 16(9):3937-40. PubMed ID: 25987064
[TBL] [Abstract][Full Text] [Related]
29. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.
Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D
Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955
[TBL] [Abstract][Full Text] [Related]
30. Insulin in the early management of diabetic complications.
Miles JM
J Assoc Physicians India; 2003 May; 51():501-5. PubMed ID: 12974435
[TBL] [Abstract][Full Text] [Related]
31. Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort.
Wahlqvist ML; Lee MS; Hsu CC; Chuang SY; Lee JT; Tsai HN
Parkinsonism Relat Disord; 2012 Jul; 18(6):753-8. PubMed ID: 22498320
[TBL] [Abstract][Full Text] [Related]
32. [Metformin, an antidiabetic molecule with anti-cancer properties].
Beck E; Scheen AJ
Rev Med Liege; 2013 Sep; 68(9):444-9. PubMed ID: 24180199
[TBL] [Abstract][Full Text] [Related]
33. [New clinical data with metformin therapy in patients with diabetes mellitus].
Jermendy G
Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
[TBL] [Abstract][Full Text] [Related]
34. Diabetes and pancreatic cancer.
Li D
Mol Carcinog; 2012 Jan; 51(1):64-74. PubMed ID: 22162232
[TBL] [Abstract][Full Text] [Related]
35. Diabetes and pancreatic cancer.
Muniraj T; Chari ST
Minerva Gastroenterol Dietol; 2012 Dec; 58(4):331-45. PubMed ID: 23207610
[TBL] [Abstract][Full Text] [Related]
36. A New Role for an Old Drug: Metformin Targets MicroRNAs in Treating Diabetes and Cancer.
Zhou JY; Xu B; Li L
Drug Dev Res; 2015 Sep; 76(6):263-9. PubMed ID: 26936407
[TBL] [Abstract][Full Text] [Related]
37. [Antidiabetic therapy--a new possibility in the complex therapy of cancer?].
Bánhegyi RJ; Rus-Gal PO; Nagy AK; Martyin T; Wágner R; Varga R; Pikó B
Magy Onkol; 2010 Dec; 54(4):315-23. PubMed ID: 21163762
[TBL] [Abstract][Full Text] [Related]
38. Metformin, an old drug, brings a new era to cancer therapy.
He H; Ke R; Lin H; Ying Y; Liu D; Luo Z
Cancer J; 2015; 21(2):70-4. PubMed ID: 25815846
[TBL] [Abstract][Full Text] [Related]
39. Metformin and survival in diabetic patients with breast cancer.
El-Benhawy SA; El-Sheredy HG
J Egypt Public Health Assoc; 2014 Dec; 89(3):148-53. PubMed ID: 25534180
[TBL] [Abstract][Full Text] [Related]
40. Crucial microRNAs and genes in metformin's anti-pancreatic cancer effect explored by microRNA-mRNA integrated analysis.
Li Y; Li L; Zhang G; Wang Y; Chen H; Kong R; Pan S; Sun B
Invest New Drugs; 2018 Feb; 36(1):20-27. PubMed ID: 28875433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
